RetinaRounds™

30: RetinaRounds™ Podcast 30: Jay Duker, MD

58 min · 21. dec. 2025
episode 30: RetinaRounds™ Podcast 30: Jay Duker, MD cover

Description

Retina Rounds is excited to welcome a true leader in ophthalmology and a giant in retina: Dr. Jay Duker. Dr. Duker is one of the most accomplished figures in our field, having served as Chair of Ophthalmology at Tufts Medical Center, where he helped shape both clinical care and research for over two decades.  He’s now President and CEO of EyePoint Pharmaceuticals and, in today’s episode, we discuss his remarkable career journey, his transition from academia to biotech, and a fascinating deep dive into tyrosine kinase inhibitors, clinical trial development, and what it really takes to bring a new therapy from concept to regulatory approval.  * Retina Rounds has no financial or conflicts of interest in the content presented

Comments

0

Be the first to comment

Sign up now and become a member of the RetinaRounds™ community!

Get Started

2 months for 19 kr.

Then 99 kr. / month · Cancel anytime.

  • Podcasts kun på Podimo
  • 20 lydbogstimer pr. måned
  • Gratis podcasts

All episodes

31 episodes

episode 30: RetinaRounds™ Podcast 30: Jay Duker, MD artwork

30: RetinaRounds™ Podcast 30: Jay Duker, MD

Retina Rounds is excited to welcome a true leader in ophthalmology and a giant in retina: Dr. Jay Duker. Dr. Duker is one of the most accomplished figures in our field, having served as Chair of Ophthalmology at Tufts Medical Center, where he helped shape both clinical care and research for over two decades.  He’s now President and CEO of EyePoint Pharmaceuticals and, in today’s episode, we discuss his remarkable career journey, his transition from academia to biotech, and a fascinating deep dive into tyrosine kinase inhibitors, clinical trial development, and what it really takes to bring a new therapy from concept to regulatory approval.  * Retina Rounds has no financial or conflicts of interest in the content presented

21. dec. 202558 min